GBE1 Antibody [P1M6]

N.º de catálogo F4945

Imprimir

Descripción biológica

Especificidad GBE1 Antibody [P1M6] detecta niveles endógenos de proteína GBE1 total.
Antecedentes GBE1 (enzima ramificadora de glucógeno 1) codifica una glicosiltransferasa vital responsable de introducir puntos de ramificación α-1,6-glucosídicos en cadenas lineales de α-1,4-glucosa, un proceso esencial para la síntesis de gránulos de glucógeno compactos y solubles predominantemente en el hígado y el músculo, apoyando así la homeostasis energética. Presenta un segmento helicoidal N-terminal, un módulo de unión a carbohidratos 48 (CBM48, residuos 76–183), un barril catalítico central (βα)8 que alberga la tríada catalítica Asp357-Glu412-Asp481 y la hendidura de unión al sustrato Tyr329, y un dominio de barril similar a la amilasa C-terminal; la mayoría de las mutaciones patógenas se agrupan en la región catalítica, interrumpiendo el plegamiento de proteínas o la actividad de transferencia de glucosilo. GBE1 opera aguas abajo de la glucógeno sintasa para generar estructuras de glucógeno ramificadas que son rápidamente movilizadas por la fosforilasa durante el ayuno o el ejercicio, crucial para el equilibrio de la glucosa. Las mutaciones bialélicas de GBE1 causan la enfermedad de almacenamiento de glucógeno tipo IV (GSD IV, enfermedad de Andersen), caracterizada por actividad enzimática ausente o reducida, acumulación de cuerpos de poliglucosano insolubles, insuficiencia hepática, miopatía y letalidad infantil en formas graves, mientras que la deficiencia parcial, como la mutación p.Tyr329Ser prevalente en judíos asquenazíes, conduce a la enfermedad de cuerpos de poliglucosano del adulto (APBD), marcada por neurodegeneración progresiva, espasticidad y vejiga neurogénica debido a la acumulación de poliglucosano en el SNC.

Información de uso

Aplicación WB Dilución
WB
1:1000 - 1:10000
Reactividad Human
Fuente Rabbit Monoclonal Antibody MW 76 kDa,80 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/26199317/
  • https://pubmed.ncbi.nlm.nih.gov/21075835/

Datos de aplicación

WB

Validado por Selleck

  • F4945-wb
    Lane 1: Human fetal liver, Lane 2: PC-3